SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS is trending after a historic post-earnings collapse triggered by soft athletic footwear demand, a guidance cut, and Foot Locker integration worries, which sparked a wave of analyst price-target cuts. Retail traders are fiercely split between calling the selloff an overreaction and bottom-fishing for a bounce, while others warn of further downside or bet on a short squeezekeeping sentiment paradoxically bullish despite the rout.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit is tumbling after its Q4 earnings beat was overshadowed by a weak FY2027 forecast, driven by a deliberate pivot to lower TurboTax pricing to counter AI-driven competition and customer churn. Retail sentiment on Stocktwits spiked to 'extremely bullish' despite the drop, with traders fiercely divided between seeing a buying opportunity and fearing deeper structural erosion from AI disruption.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

ASST is trending as Bitcoin's rally fuels a surge in the Bitcoin-treasury stock, with traders highlighting high short interest and the potential for a squeeze amid the CEO's recent $80M+ BTC purchase and bullish analyst commentary.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending on the market's reaction to its exclusive global licensing deal for VEPPANU, the first FDA-approved PROTAC for breast cancer, which investors see as a major growth catalyst and potential short-squeeze trigger. The community is focused on the drug's commercial launch potential and the company's undervaluation relative to its expanding pipeline and profitability.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is surging on Washingtons $1.55B rareearth funding package, fueling broad sector optimism and retail traders betting on a short squeeze. Sentiment on Stocktwits has flipped to bullish with message volume at extreme highs, while some users warn the excitement might be overdone and the move could reverse.

Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of brand names, including Nature’s Own, Dave’s Killer Bread, Wonder, Canyon Bakehouse, Tastykake, and Mrs. Freshley’s. The company was founded by William Howard Flowers, Sr. and Joseph Hampton Flowers, Jr. in 1919 and is headquartered in Thomasville, GA.

Flowers Foods, Inc.

Flowers Foods is trending after its Q2 earnings miss and full-year guidance cut sparked a sharp selloff, with traders debating whether the dividend is safe given declining volumes and margins or if the low valuation presents a buying opportunity.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

$CSIQ trading is highly active amid a mix of retail speculation on an imminent earnings report and legal/regulatory scrutiny, with chatter focused on a potential short squeeze and allegations of market manipulation. Broader sector momentum and catalysts like upcoming 45X credits and the subsidiary share lock-up expiry are also key talking points.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as retail traders aggressively debate the impending Phase 3 REGAL trial readout for its cancer immunotherapy GPS, with bulls pointing to an imminent 80th clinical event and potential buyout while bears question the company's data integrity and timeline. The stock has become a battleground between bullish investors predicting a major value unlock and skeptical traders accusing the company of manipulation and inflated market expectations.

CF Acquisition Corp. VI operates as a blank check company. It focuses on the search of companies in the financial services, healthcare, real estate services, technology and software industries. The company was founded on April 17, 2020 and is headquartered in New York, NY.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is surging after securing a $13.7 billion, six-year GPU services contract for its Quake AI data center unit from an unnamed U.S. cloud customer. The community is intensely speculating on the mystery client's identity, while debating the deal's massive scale against the company's financing needs and the potential for a short squeeze given elevated short interest.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

ARCT is surging over 60% toward its best week in a year, lifted by sector-wide enthusiasm from Moderna's cancer vaccine win. Retail sentiment is increasingly bullish on ARCT's proprietary self-amplifying mRNA platform, Kostaive commercial sales, and upcoming pipeline catalysts, fueling discussions of a potential short squeeze and buyout premium, though the stock is now technically overbought with an RSI above 90.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bernstein upgrades Sartorius to “outperform” on margin recovery, pharma demand

RBC upgrades Sartorius stocks as recent pullback ’provides entry opportunity’ 

Sartorius AG and its biotech subsidiary lifted to Buy at Barclays

Investing.com -- Barclays has upgraded Sartorius AG (F:SATG) and its subsidiary Sartorius  Stedim  (EPA:STDM) Biotech SA (VIE:DIM) to Overweight, citing a shift in the bioprocessing industry toward a post-COVID recovery.

Sartorius shares soar 11% on strong Q4, order intake drives rally

Themes ETF Trust - Leverage Shares 2X Long ECHO Daily ETF

Bullish Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Current Price	$7.53
Prev Close	$7.32
Open	$7.44
Dividend Yield	N/A
50-Day Moving Average	$9.35
Beta	N/A
Avg. Volume	210,652.13
PE Ratio	N/A

52-Week High	$24.99
52-Week Low	$7.02
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info